- Growing regulatory pressure from agencies such as the EMA (Asia-Pacifican Medicines Agency) and MHRA is driving demand for advanced packaging testing solutions that ensure data integrity, repeatability, and compliance with Good Manufacturing Practice (GMP) standards
- For instance: in February 2024, Sepha Ltd. launched a new generation of vacuum decay testers in the EU market, compliant with USP <1207> standards and equipped with digital data logging systems to support regulatory audits
- Increasing adoption of fully automated and integrated packaging testing equipment enables real-time monitoring, traceability, and consistent quality across pharmaceutical production lines
- Innovations in non-destructive testing (NDT) technologies, such as vacuum decay, laser-based leak detection, and high-resolution imaging, are improving test accuracy without damaging packaging
- This trend reflects the industry’s broader shift toward digitized, standardized, and highly compliant testing infrastructure to meet stringent pharmaceutical packaging validation requirements
